These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3564858)

  • 21. [Blood uric acid in myeloma].
    Caplain-Dandine F; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):1-4. PubMed ID: 834952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The additional role of bone marrow particle sections ('clot sections') in confirming marrow involvement by multiple myeloma: a single centre study.
    Mathur K; Soutar R
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e179-80. PubMed ID: 19196378
    [No Abstract]   [Full Text] [Related]  

  • 23. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
    Sher T; Miller KC; Lee K; Chanan-Khan A
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of multiple myeloma.
    Alexanian R; Dimopoulos MA
    Semin Hematol; 1995 Jan; 32(1):20-30. PubMed ID: 7878475
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple myeloma with an orbital tumor during complete remission with relapse and death in an aggressive phase].
    Kajitani H; Saito K; Okuyama A; Osato M; Watanabe K; Yamazaki T; Hamaguchi H; Sakamaki H; Enokihara H; Furusawa S
    Rinsho Ketsueki; 1986 Apr; 27(4):594-9. PubMed ID: 3735700
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
    Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
    Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies of bone marrow smears and bone marrow biopsy in diffuse plasmocytoma].
    PAPAGEORGIOU A; SCHMITT-ROHDE JM
    Dtsch Arch Klin Med; 1960; 206():574-82. PubMed ID: 13732604
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of bone marrow fibrosis in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prognostic significance of cytological study of the bone marrow in multiple myeloma].
    Iakovleva SV
    Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
    Schmidt U; Ruwe M; Leder LD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma in two young postpartum women.
    Harster GA; Krause JR
    Arch Pathol Lab Med; 1987 Jan; 111(1):38-42. PubMed ID: 3800603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 35. [Micromolecular multiple myeloma, hypertension and nephropathy].
    Medicina (B Aires); 1995; 55(4):347-54. PubMed ID: 8728877
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
    Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
    Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concerning the condition of the bone marrow in patients with multiple myeloma].
    Rekhtina IG; Bel'chenko DI
    Vopr Onkol; 2004; 50(3):351-4. PubMed ID: 15318712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current problems in the diagnosis and treatment of myeloma disease].
    Alekseev GA
    Klin Med (Mosk); 1983 May; 61(5):8-12. PubMed ID: 6348403
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications].
    de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML
    Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
    Bernat S; Gozalbo T; García-Boyero R; Guinot M
    Sangre (Barc); 1998 Feb; 43(1):96-7. PubMed ID: 9577192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.